Vegf Trap News
Most Popular Vegf Trap Story
Regeneron gets $20M milestone from Bayer
Regeneron Pharmaceuticals has enrolled the first patient in a Phase III trial of VEGF Trap-Eye for the treatment of central retinal vein occlusion, triggering a $20 million milestone payment form Read more...
Latest Headlines
- February 17, 2011
- February 18, 2010
- July 24, 2009
- August 23, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
